The risks of adverse events with venlafaxine and mirtazapine versus ‘active placebo’, placebo, or no intervention for adults with major depressive disorder: a protocol for two separate systematic reviews with meta-analysis and Trial Sequential Analysis

CK Jorgensen; S Juul; F Siddiqui; MA Horowitz; J Moncrieff; K Munkholm; MP Hengartner; I Kirsch; C Gluud; JC Jakobsen

The risks of adverse events with venlafaxine and mirtazapine versus ‘active placebo’, placebo, or no intervention for adults with major depressive disorder: a protocol for two separate systematic reviews with meta-analysis and Trial Sequential Analysis

CK Jorgensen, S Juul, F Siddiqui, MA Horowitz, J Moncrieff, K Munkholm, MP Hengartner, I Kirsch, C Gluud, JC Jakobsen

Kalaidos School of Applied Psychology

Research output: Contribution to journal › Article › peer-review

Original language	Undefined/Unknown
Pages (from-to)	57
Number of pages	1
Journal	Systematic Reviews
Volume	12
Publication status	Published - 2023

Cite this

Jorgensen, CK., Juul, S., Siddiqui, F., Horowitz, MA., Moncrieff, J., Munkholm, K., Hengartner, MP., Kirsch, I., Gluud, C., & Jakobsen, JC. (2023). The risks of adverse events with venlafaxine and mirtazapine versus ‘active placebo’, placebo, or no intervention for adults with major depressive disorder: a protocol for two separate systematic reviews with meta-analysis and Trial Sequential Analysis. Systematic Reviews, 12, 57.

@article{7c59be30329742e199f7f39e44ec37a7,

title = "The risks of adverse events with venlafaxine and mirtazapine versus {\textquoteleft}active placebo{\textquoteright}, placebo, or no intervention for adults with major depressive disorder: a protocol for two separate systematic reviews with meta-analysis and Trial Sequential Analysis",

author = "CK Jorgensen and S Juul and F Siddiqui and MA Horowitz and J Moncrieff and K Munkholm and MP Hengartner and I Kirsch and C Gluud and JC Jakobsen",

year = "2023",

language = "undefiniert/unbekannt",

volume = "12",

pages = "57",

journal = "Systematic Reviews",

}

Jorgensen, CK, Juul, S, Siddiqui, F, Horowitz, MA, Moncrieff, J, Munkholm, K, Hengartner, MP, Kirsch, I, Gluud, C & Jakobsen, JC 2023, 'The risks of adverse events with venlafaxine and mirtazapine versus ‘active placebo’, placebo, or no intervention for adults with major depressive disorder: a protocol for two separate systematic reviews with meta-analysis and Trial Sequential Analysis', Systematic Reviews, vol. 12, pp. 57.

The risks of adverse events with venlafaxine and mirtazapine versus ‘active placebo’, placebo, or no intervention for adults with major depressive disorder: a protocol for two separate systematic reviews with meta-analysis and Trial Sequential Analysis. / Jorgensen, CK; Juul, S; Siddiqui, F et al.
In: Systematic Reviews, Vol. 12, 2023, p. 57.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - The risks of adverse events with venlafaxine and mirtazapine versus ‘active placebo’, placebo, or no intervention for adults with major depressive disorder: a protocol for two separate systematic reviews with meta-analysis and Trial Sequential Analysis

AU - Jorgensen, CK

AU - Juul, S

AU - Siddiqui, F

AU - Horowitz, MA

AU - Moncrieff, J

AU - Munkholm, K

AU - Hengartner, MP

AU - Kirsch, I

AU - Gluud, C

AU - Jakobsen, JC

PY - 2023

Y1 - 2023

M3 - Artikel

VL - 12

SP - 57

JO - Systematic Reviews

JF - Systematic Reviews

ER -